Akzo Nobel NV

Pharmaceuticals
Netherlands
Earnings Per Share Growth (%)76.58%
Cost of Goods Sold (US$ Millions)$9,568
Current Liabilities (US$ Millions)$5,007
Total Assets (US$ Millions)$6,186
Long Term Debt$2,354
Return on Equity16.91%
Revenue (US$ Millions)$16,185
Total Company Assets$17,387
Revenue Growth (%)3.94%
Net Income (US$ Millions)$1,066
Earnings Per Share (US$)$76.58
Total Equity (US$ Millions)$7,062
Profit Margin (%)6.59%
Debt To Equity Ratio (%)0.33%
Inventory Turnover$1,638